Stoke Therapeutics, Inc. SEC filings STOK

Stoke Therapeutics, Inc. has 632 filings in SEC EDGAR's recent list, going back to Nov 24, 2014. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Stoke Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
4 Insider transaction Nov 4, 2026 Nov 2, 2026
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
144 Notice of proposed sale Oct 21, 2026 —
4 Insider transaction Oct 2, 2026 Oct 2, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 2, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Sep 30, 2026 —
4 Insider transaction Sep 25, 2026 Sep 23, 2026
3 Initial insider ownership Sep 25, 2026 Sep 23, 2026
8-K Current report
Officer or director change
Sep 25, 2026 Sep 22, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
8-K Current report
Other events
Aug 3, 2026 Aug 3, 2026
424B5 Prospectus supplement Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
S-8 Employee stock plan registration Aug 3, 2026 —
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
4 Insider transaction Jul 17, 2026 Jul 16, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
3 Initial insider ownership Jul 17, 2026 Jul 13, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2026 Jun 30, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
4 Insider transaction May 5, 2026 May 1, 2026
144 Notice of proposed sale May 1, 2026 —
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 3, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
3 Initial insider ownership Apr 7, 2026 Apr 3, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 7, 2026 Apr 3, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
8-K Current report
Auditor change
Mar 27, 2026 Mar 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 24, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 20, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 19, 2026 —
S-3ASR Automatic shelf registration Mar 18, 2026 —
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
S-8 Employee stock plan registration Mar 16, 2026 —
10-K Annual report Mar 16, 2026 Dec 31, 2025
144 Notice of proposed sale Mar 13, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 10, 2026 —
4 Insider transaction Mar 4, 2026 Mar 2, 2026
8-K Current report
Officer or director change
Mar 3, 2026 Feb 13, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
8-K Current report
Material agreement, New debt
Jan 26, 2026 Jan 21, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 12, 2026 Jan 11, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 8, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 5, 2025 —
144 Notice of proposed sale Dec 5, 2025 —
144 Notice of proposed sale Dec 5, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 5, 2025 Dec 5, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 24, 2025 —
4 Insider transaction Nov 18, 2025 Nov 14, 2025
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 5, 2025 Nov 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
144 Notice of proposed sale Nov 3, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 14, 2025 Oct 8, 2025
4 Insider transaction Oct 10, 2025 Oct 8, 2025
144 Notice of proposed sale Oct 8, 2025 —
4 Insider transaction Oct 7, 2025 Oct 3, 2025
4 Insider transaction Oct 7, 2025 Oct 3, 2025
8-K Current report
Officer or director change
Oct 6, 2025 Oct 5, 2025
144 Notice of proposed sale Oct 3, 2025 —
144 Notice of proposed sale Oct 3, 2025 —
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
8-K/A Amended current report
Shareholder vote results
Sep 18, 2025 Jun 3, 2025
4 Insider transaction Sep 5, 2025 Sep 4, 2025
4 Insider transaction Sep 3, 2025 Sep 2, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Aug 29, 2025 —
144 Notice of proposed sale Aug 29, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 26, 2025 —
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
144 Notice of proposed sale Aug 13, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
8-K Current report
Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
4 Insider transaction Aug 5, 2025 Aug 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 15, 2025 —
EFFECT Filing Jul 11, 2025 —
8-K Current report
Regulation FD disclosure
Jul 10, 2025 Jul 10, 2025
CORRESP Letter to the SEC Jul 9, 2025 —
S-8 Employee stock plan registration Jul 9, 2025 —
S-3 Shelf registration Jul 9, 2025 —
4 Insider transaction Jul 2, 2025 Jul 1, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
144 Notice of proposed sale Jul 1, 2025 —
UPLOAD Letter from the SEC Jun 30, 2025 —
DRSLTR Filing Jun 26, 2025 —
DRS Filing Jun 26, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 23, 2025 —
3 Initial insider ownership Jun 23, 2025 Jun 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 6, 2025 —
4 Insider transaction Jun 6, 2025 Jun 4, 2025
SCHEDULE 13G Ownership over 5% (passive) Jun 6, 2025 —
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
8-K Current report
Shareholder vote results
Jun 4, 2025 Jun 3, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2025 Jun 4, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
4 Insider transaction May 5, 2025 May 1, 2025
144 Notice of proposed sale May 1, 2025 —
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 16, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Apr 15, 2025 —
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Mar 20, 2025 Mar 20, 2025
4 Insider transaction Mar 20, 2025 Mar 20, 2025
4 Insider transaction Mar 20, 2025 Mar 20, 2025
4 Insider transaction Mar 20, 2025 Mar 19, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
S-8 Employee stock plan registration Mar 18, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
STOK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedford, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1623526
Former names
ASOthera Pharmaceuticals, Inc. (until Nov 24, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.